NeuPath Health Statistics

Total Valuation

NeuPath Health has a market cap or net worth of CAD 32.63 million. The enterprise value is 41.63 million.

Market Cap	32.63M
Enterprise Value	41.63M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

NeuPath Health has 56.26 million shares outstanding. The number of shares has increased by 2.40% in one year.

Current Share Class	56.26M
Shares Outstanding	56.26M
Shares Change (YoY)	+2.40%
Shares Change (QoQ)	-3.51%
Owned by Insiders (%)	3.01%
Owned by Institutions (%)	10.97%
Float	49.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	7.25
PS Ratio	0.37
PB Ratio	1.56
P/TBV Ratio	n/a
P/FCF Ratio	9.93
P/OCF Ratio	8.15
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.62, with an EV/FCF ratio of 12.67.

EV / Earnings	-58.06
EV / Sales	0.48
EV / EBITDA	9.62
EV / EBIT	20.44
EV / FCF	12.67

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.63.

Current Ratio	1.09
Quick Ratio	1.03
Debt / Equity	0.63
Debt / EBITDA	3.04
Debt / FCF	4.00
Interest Coverage	2.27

Financial Efficiency

Return on equity (ROE) is -1.95% and return on invested capital (ROIC) is 6.82%.

Return on Equity (ROE)	-1.95%
Return on Assets (ROA)	2.95%
Return on Invested Capital (ROIC)	6.82%
Return on Capital Employed (ROCE)	6.30%
Weighted Average Cost of Capital (WACC)	8.54%
Revenue Per Employee	573,638
Profits Per Employee	-4,717
Employee Count	152
Asset Turnover	2.02
Inventory Turnover	n/a

Taxes

In the past 12 months, NeuPath Health has paid 356,000 in taxes.

Income Tax	356,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +202.56% in the last 52 weeks. The beta is 1.01, so NeuPath Health's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	+202.56%
50-Day Moving Average	0.50
200-Day Moving Average	0.41
Relative Strength Index (RSI)	58.04
Average Volume (20 Days)	100,082

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NeuPath Health had revenue of CAD 87.19 million and -717,000 in losses. Loss per share was -0.01.

Revenue	87.19M
Gross Profit	16.59M
Operating Income	2.04M
Pretax Income	-57,000
Net Income	-717,000
EBITDA	3.04M
EBIT	2.04M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 4.47 million in cash and 13.14 million in debt, giving a net cash position of -8.67 million or -0.15 per share.

Cash & Cash Equivalents	4.47M
Total Debt	13.14M
Net Cash	-8.67M
Net Cash Per Share	-0.15
Equity (Book Value)	20.95M
Book Value Per Share	0.37
Working Capital	1.13M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.00 million and capital expenditures -718,000, giving a free cash flow of 3.29 million.

Operating Cash Flow	4.00M
Capital Expenditures	-718,000
Depreciation & Amortization	1.01M
Net Borrowing	-1.39M
Free Cash Flow	3.29M
FCF Per Share	0.06

Full Cash Flow Statement

Margins

Gross margin is 19.03%, with operating and profit margins of 2.34% and -0.82%.

Gross Margin	19.03%
Operating Margin	2.34%
Pretax Margin	-0.07%
Profit Margin	-0.82%
EBITDA Margin	3.49%
EBIT Margin	2.34%
FCF Margin	3.77%

Dividends & Yields

NeuPath Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.40%
Shareholder Yield	-2.40%
Earnings Yield	-2.20%
FCF Yield	10.07%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NeuPath Health has an Altman Z-Score of 1.65 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.65
Piotroski F-Score	5